<DOC>
	<DOC>NCT02213497</DOC>
	<brief_summary>Patients with esophageal cancer to be treated with concurrent preoperative proton therapy along with carboplatin and paclitaxel.</brief_summary>
	<brief_title>Dose Escalation of Neoadjuvant Proton Beam Radiotherapy With Concurrent Chemotherapy in Locally Advanced Esophageal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>Patients with a histologic diagnosis of adenocarcinoma of the esophagus located distal to the carina Patients with AJCC 7th edition clinical stage IIBIIIC Patient must be &gt;18 years of age. Patients must have an ECOG Performance Status of 01 Patients must be able to provide informed consent. Patients must be surgical candidates with adequate hematologic, renal, hepatic and pulmonary function serum AST and ALT &lt; 2 times the upper limit of normal Patients must have bilirubin &lt; 1.5 Ã— normal. WBC &gt; 3000/mm3, platelets &gt; 100,000 mm3. Hemoglobin &gt; 10 g/dL serum creatinine &lt; 1.5 times the upper limit of normal Women of childbearing potential as long as she agrees to use a recognized method of birth control (e.g. oral contraceptive, IUD, condoms or other barrier methods etc.). Hysterectomy or menopause must be clinically documented. Patients with primary tumors exceeding 8 cm in length or 5 cm in width ( length should be measured by endoscopic findings, width should be measured by diagnostic CT or CT portion of PET/CT) Patients with primary tumors located at or above the carina Prior or simultaneous malignancies within the past two years (other than cutaneous squamous or basal cell carcinoma, melanoma in situ or thyroid carcinoma) Pregnant women, women planning to become pregnant and women that are nursing</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Patients with esophageal cancer to be treated with concurrent preoperative chemoradiation with carboplatin and paclitaxel.</keyword>
</DOC>